(Q73047135)

English

Antitumor agents. 168. Dysoxylum cumingianum. IV. The structures of cumingianosides G-O, new triterpene glucosides with a 14,18-cycloapotirucallane-type skeleton from Dysoxylum cumingianum, and their cytotoxicity against human cancer cell lines

scientific article published on 01 January 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023969%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Antitumor agents. 168. Dysoxylum cumingianum. IV. The structures of cumingianosides G-O, new triterpene glucosides with a 14,18-cycloapotirucallane-type skeleton from Dysoxylum cumingianum, and their cytotoxicity against human cancer cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023969%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Dysoxylum cumingianum

1 reference

cumingianoside A

1 reference

Cumingianoside L

1 reference

[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[[(1S,2R,3R,5R,7R,10S,11R,14R,15S)-7-hydroxy-2,6,6,10-tetramethyl-15-[(2S,4R,5S)-4,5,6-trihydroxy-6-methylheptan-2-yl]-3-pentacyclo[12.3.1.01,14.02,11.05,10]octadecanyl]oxy]oxan-2-yl]methyl acetate

1 reference

[(1S,2R,3R,5R,7R,10S,11R,14R,15S)-3-[(2R,3R,4R,5S,6R)-5-acetyloxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,6,6,10-tetramethyl-15-[(2S,4R,5S)-4,5,6-trihydroxy-6-methylheptan-2-yl]-7-pentacyclo[12.3.1.01,14.02,11.05,10]octadecanyl] acetate

1 reference

Cumingianoside M

1 reference

Cumingianoside I

1 reference

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(1S,2R,3R,5R,7R,10S,11R,14R,15S)-7-hydroxy-2,6,6,10-tetramethyl-15-[(2S,4R,5S)-4,5,6-trihydroxy-6-methylheptan-2-yl]-3-pentacyclo[12.3.1.01,14.02,11.05,10]octadecanyl]oxy]oxane-3,4,5-triol

1 reference

Cumingianoside K

1 reference

[(2R,3S,4S,5R,6R)-6-[[(1S,2R,3R,5R,7R,10S,11R,14R,15S)-7-acetyloxy-2,6,6,10-tetramethyl-15-[(2S,4S,5S)-4,5,6-trihydroxy-6-methylheptan-2-yl]-3-pentacyclo[12.3.1.01,14.02,11.05,10]octadecanyl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate

1 reference

Cumingianoside G

1 reference

[(2R,3S,4S,5R,6R)-6-[[(1S,2R,3R,5R,7R,10S,11R,14R,15S)-7-acetyloxy-15-[(2S)-1-[(2R,3R)-3-hydroxy-4,4-dimethyloxetan-2-yl]propan-2-yl]-2,6,6,10-tetramethyl-3-pentacyclo[12.3.1.01,14.02,11.05,10]octadecanyl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate

1 reference

Cumingianoside H

1 reference

[(1S,2R,3R,5R,7R,10S,11R,14R,15S)-15-[(2S,4R,5R)-4,5-dihydroxy-6-methylhept-6-en-2-yl]-2,6,6,10-tetramethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7-pentacyclo[12.3.1.01,14.02,11.05,10]octadecanyl] acetate

1 reference

(1S,2R,3R,5R,10R,11R,14R,15S)-2,6,6,10-tetramethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-15-[(2S,4R,5S)-4,5,6-trihydroxy-6-methylheptan-2-yl]pentacyclo[12.3.1.01,14.02,11.05,10]octadecan-7-one

1 reference

cumingianoside F

1 reference

cumingianoside E

1 reference

Cumingianoside J

1 reference

[(1S,2R,3R,5R,7R,10S,11R,14R,15S)-3-[(2R,3R,4S,5R,6R)-4-acetyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,6,6,10-tetramethyl-15-[(2S,4R,5S)-4,5,6-trihydroxy-6-methylheptan-2-yl]-7-pentacyclo[12.3.1.01,14.02,11.05,10]octadecanyl] acetate

1 reference

cumingianoside C

1 reference

cumingianoside B

1 reference

cumingianoside D

1 reference

[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[[(1S,2R,3R,5R,10R,11R,14R,15S)-2,6,6,10-tetramethyl-7-oxo-15-[(2S,4R,5S)-4,5,6-trihydroxy-6-methylheptan-2-yl]-3-pentacyclo[12.3.1.01,14.02,11.05,10]octadecanyl]oxy]oxan-2-yl]methyl acetate

1 reference

0 references

Epicharis cumingiana

1 reference

author name string

T Fujioka

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023969%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A Sakurai

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023969%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K Mihashi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023969%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Y Kashiwada

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023969%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

I S Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023969%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K H Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023969%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

1 reference

Chemical & Pharmaceutical Bulletin

publication date

1997

1 reference

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/cpb1958/45/1/45_1_68/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.45.68?email=unpaywall_01@example.com

Chemical & Pharmaceutical Bulletin

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023969%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023969%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023969%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

68-74

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023969%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.45.68?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

Identifiers

10.1248/CPB.45.68

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023969%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9023969%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73047135&oldid=2106804063"